Professor Joanna Wardlaw

Researchers find that stroke survivors are more able to look after themselves following treatment with rt-PA.

Professor Wardlaw discusses clot busting treatments and neuroimaging research.

Clot busting treatment

Patients given a clot-busting drug within six hours of a stroke are more likely to make a better recovery than those who do not receive the treatment.

The multi-centre, randomised study of more than 3000 patients is the world's largest ever trial of the drug rt-PA, which is given intravenously to patients who have suffered an acute ischemic stroke.

The international trial - known as IST-3 - has found that for every 1000 patients given the clot-busting treatment within three hours of stroke, 80 more will survive & live without help from others than if they had not been given the drug.

The findings of the study, led by the University, have been published in The Lancet alongside an analysis of all other trials of the drug that have been carried out in the past 20 years.

Professor Joanna Wardlaw on clot bursting treatment.

Neuroimaging research

Prof Wardlaw discusses Stroke and Small Vessel Disease in Neuroimaging research.

Professor Joanna Wardlaw on neuroimaging research.